Category: Thomson ReutersSyndicate content

VC spend in life sciences grew in 2011 | Wall Street Beat

February 2, 2012 by MassDevice staff

Venture capital investors spent 21% more backing life science startups in 2011 than in 2010, according to PricewaterhouseCoopers; also, VCs in the Valley lose confidence; Greenway Medical prices IPO; does Abbott need a new CEO?; and analysts' ups and downs. Wall Street Beat

Venture capital funding of life science startups, including biotech and medical device enterprises, rose by 21% last year, according to PricewaterhouseCoopers.

VCs dropped $7.5 billion on 785 life sciences deals during the year, according to a PwC report, "Zigzagging Upward," compiled using data from the PricewaterhouseCoopers LLP/National Venture Capital Assn. MoneyTree Report and Thomson Reuters.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp